| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0043 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |